The Role of Early Nursing Intervention in the High-risk Population of Gestational Diabetes
Key facts
- Who runs it
- Yan Lu
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 200 people, planned
- Started
- 1 Jan 2025
- Ended
- 30 Sept 2025
- Type of study
- Interventional, 2 groups
- Treatments tested
- Control group:The interactive management nursing model on the wechat platform
- Intervention group:Family-centered early care intervention
- Record updated
- 30 May 2025
Who can take part
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 22 criteriaShow less
Who can take part
- Gestational age <10 weeks Singleton pregnancy confirmed by first-trimester ultrasound
- Primary caregiver availability: At least one primary caregiver (spouse or parent) who:
- Demonstrates adequate verbal communication and literacy skills (assessed by standardized evaluation)
- Voluntarily participates in the study with signed informed consent; Metabolic risk factors meeting ≥1 criterion:
- Pre-pregnancy BMI >24 kg/m²
- Maternal age ≥35 years at conception
- Documented history of polycystic ovary syndrome (PCOS)
- Fasting blood glucose (FBG) ≥5.1 mmol/L in early pregnancy
- Parental history of diabetes mellitus (either parent)
- Previous gestational diabetes mellitus (GDM)
- History of macrosomia (birth weight ≥4000g)
- Adverse obstetric history including:; Preterm delivery (<37 weeks) Stillbirth or fetal demise Congenital malformations Neonatal death or unexplained neonatal death
Who cannot take part
- Systemic corticosteroids (e.g., cortisone, prednisone); Activity-limiting comorbidities:
- Pre-existing medical conditions:
- Chronic hypertension (diagnosed pre-pregnancy)
- Renal disorders (e.g., chronic kidney disease stage ≥3)
- Cardiovascular diseases (e.g., coronary artery disease, heart failure); Prohibited medication use during pregnancy including:
- Severe medical complications contraindicating physical activity (e.g., unstable angina, advanced respiratory failure)
- Indomethacin
- Phentolamine
- Diuretics (e.g., furosemide, hydrochlorothiazide)
- Phenytoin
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Pregnant women who established prenatal examination cards in the prenatal outpatient department of our hospital from January 2025 to September 2025 were selected. According to the inclusion criteria, 200 high-risk pregnant women with gestational diabetes mellitus (GDM) were selected. 100 people in the control group received conventional nursing intervention measures, and 100 people in the intervention group adopted the family-centered wechat platform interactive management nursing model. The observation period was from the start of prenatal examination to follow-up until delivery. The blood glucose conditions, glycated hemoglobin (HbA1c) levels, incidence of GDM, and weight gain during pregnancy of the two groups of pregnant women were observed. The pregnancy outcomes included: Gestational age at delivery, gestational complications (gestational hypertension, diabetic ketosis, preterm birth, post-term pregnancy, urogenital tract infection), polyhydramnios, mode of delivery (induced labor, shoulder dystocia, cesarean section), premature rupture of membranes, postpartum complications (postpartum hemorrhage, puerperal infection), etc. Perinatal outcomes: including fetal growth restriction, macrosomia, preterm birth, stillbirth, fetal malformations, fetal distress, neonatal respiratory distress syndrome, neonatal hypoglycemia, etc. We applied FCC to pregnant women at high risk of gestational diabetes mellitus (GDM) and advanced the intervention window to the beginning of prenatal examination (8-10 weeks of pregnancy). This may be able to improve weight gain and blood glucose levels during pregnancy in high-risk pregnant women, reduce the incidence of GDM, improve the final maternal and infant outcomes, and provide a certain theoretical basis for prenatal nursing intervention in pregnant women at high risk of GDM in the future.
The 2 groups in the trial
- Control groupTreatment being tested
Treatment: Control group:The interactive management nursing model on the wechat platform
- Intervention groupTreatment being tested
Treatment: Intervention group:Family-centered early care intervention
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Research on the Preventive Effect of Family-centered Early Nursing Intervention on High-risk Population of Gestational Diabetes Mellitus
- Record updated
- 30 May 2025